Journal details
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM
SAGE PUBLICATIONS LTD · ISSN 2042-0188 · eISSN 2042-0196
SCIEScopusPMCDOAJ
Overview
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM. ISSN 2042-0188 · eISSN 2042-0196. published by SAGE PUBLICATIONS LTD. England. Endocrinology & Metabolism. impact factor 7.8 (2025). JCR Q1. CAS Zone 3. indexed in SCIE, Scopus, PMC, DOAJ. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 39 articles · 2025: 61 articles · 2024: 39 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM?
The impact factor recorded for THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM is 7.8 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM?
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM is listed in CAS Zone 3.
Which databases index THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM?
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM is indexed in SCIE, Scopus, PMC, DOAJ. Confirm on the journal website and the database itself before submitting.